| Kathleen Clark, DO | |
|
1234 Napier Ave, Saint Joseph, MI 49085 | |
| (269) 982-4941 | |
| Not Available |
| Full Name | Kathleen Clark |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 10 Years |
| Location | 1234 Napier Ave, Saint Joseph, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164836557 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 5101021292 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prisma Health Greenville Memorial Hospital | Greenville, SC | Hospital |
| Prisma Health Hillcrest Hospital | Simpsonville, SC | Hospital |
| Prisma Health Oconee Memorial Hospital | Seneca, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prisma Health University Medical Group | 8325950983 | 2201 |
News Archive
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the National Cancer Institute.
Researchers at the Johns Hopkins University School of Medicine, Johns Hopkins University Department of Chemical and Biomolecular Engineering, and Federal University of Rio de Janeiro in Brazil have designed a DNA-loaded nanoparticle that can pass through the mucus barrier covering conducting airways of lung tissue — proving the concept, they say, that therapeutic genes may one day be delivered directly to the lungs to the levels sufficient to treat cystic fibrosis (CF), chronic obstructive pulmonary disease, asthma and other life-threatening lung diseases.
In this Kaiser Health News column, Grace-Marie Turner writes that Massachusetts' health reform has increased demand without increasing the supply of health care providers, it continues to keep people in the dark about the true cost of health care and health insurance, and has not changed incentives for people to seek more affordable options or for a truly competitive marketplace.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented positive results from two pivotal Phase 3 clinical trials of the investigational product, PA32540, at The American Heart Association (AHA) Scientific Sessions 2012, as Poster #12057: Treatment Continuation and Cardiovascular Safety of Antiplatelet Therapy with PA32540, A Tablet with Enteric-Coated Aspirin and Immediate-Release Omeprazole: Results of Two 6-Month, Phase 3 Studies.
Workers who lost their job through no fault of their own were twice as likely as continuously employed workers to report over the next 18 months that they developed a new illness, such as high blood pressure, diabetes or heart disease, according to a study released last week, the New York Times reports.
› Verified 7 days ago
| Entity Name | Prisma Health University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295763217 PECOS PAC ID: 8325950983 Enrollment ID: O20031103000238 |
News Archive
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the National Cancer Institute.
Researchers at the Johns Hopkins University School of Medicine, Johns Hopkins University Department of Chemical and Biomolecular Engineering, and Federal University of Rio de Janeiro in Brazil have designed a DNA-loaded nanoparticle that can pass through the mucus barrier covering conducting airways of lung tissue — proving the concept, they say, that therapeutic genes may one day be delivered directly to the lungs to the levels sufficient to treat cystic fibrosis (CF), chronic obstructive pulmonary disease, asthma and other life-threatening lung diseases.
In this Kaiser Health News column, Grace-Marie Turner writes that Massachusetts' health reform has increased demand without increasing the supply of health care providers, it continues to keep people in the dark about the true cost of health care and health insurance, and has not changed incentives for people to seek more affordable options or for a truly competitive marketplace.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented positive results from two pivotal Phase 3 clinical trials of the investigational product, PA32540, at The American Heart Association (AHA) Scientific Sessions 2012, as Poster #12057: Treatment Continuation and Cardiovascular Safety of Antiplatelet Therapy with PA32540, A Tablet with Enteric-Coated Aspirin and Immediate-Release Omeprazole: Results of Two 6-Month, Phase 3 Studies.
Workers who lost their job through no fault of their own were twice as likely as continuously employed workers to report over the next 18 months that they developed a new illness, such as high blood pressure, diabetes or heart disease, according to a study released last week, the New York Times reports.
› Verified 7 days ago
| Entity Name | Baptist Easley Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144452889 PECOS PAC ID: 0840337606 Enrollment ID: O20091027000684 |
News Archive
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the National Cancer Institute.
Researchers at the Johns Hopkins University School of Medicine, Johns Hopkins University Department of Chemical and Biomolecular Engineering, and Federal University of Rio de Janeiro in Brazil have designed a DNA-loaded nanoparticle that can pass through the mucus barrier covering conducting airways of lung tissue — proving the concept, they say, that therapeutic genes may one day be delivered directly to the lungs to the levels sufficient to treat cystic fibrosis (CF), chronic obstructive pulmonary disease, asthma and other life-threatening lung diseases.
In this Kaiser Health News column, Grace-Marie Turner writes that Massachusetts' health reform has increased demand without increasing the supply of health care providers, it continues to keep people in the dark about the true cost of health care and health insurance, and has not changed incentives for people to seek more affordable options or for a truly competitive marketplace.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented positive results from two pivotal Phase 3 clinical trials of the investigational product, PA32540, at The American Heart Association (AHA) Scientific Sessions 2012, as Poster #12057: Treatment Continuation and Cardiovascular Safety of Antiplatelet Therapy with PA32540, A Tablet with Enteric-Coated Aspirin and Immediate-Release Omeprazole: Results of Two 6-Month, Phase 3 Studies.
Workers who lost their job through no fault of their own were twice as likely as continuously employed workers to report over the next 18 months that they developed a new illness, such as high blood pressure, diabetes or heart disease, according to a study released last week, the New York Times reports.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen Clark, DO 1 Independence Pt Ste 212, Greenville, SC 29615-4536 Ph: (864) 797-6174 | Kathleen Clark, DO 1234 Napier Ave, Saint Joseph, MI 49085 Ph: (269) 982-4941 |
News Archive
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the National Cancer Institute.
Researchers at the Johns Hopkins University School of Medicine, Johns Hopkins University Department of Chemical and Biomolecular Engineering, and Federal University of Rio de Janeiro in Brazil have designed a DNA-loaded nanoparticle that can pass through the mucus barrier covering conducting airways of lung tissue — proving the concept, they say, that therapeutic genes may one day be delivered directly to the lungs to the levels sufficient to treat cystic fibrosis (CF), chronic obstructive pulmonary disease, asthma and other life-threatening lung diseases.
In this Kaiser Health News column, Grace-Marie Turner writes that Massachusetts' health reform has increased demand without increasing the supply of health care providers, it continues to keep people in the dark about the true cost of health care and health insurance, and has not changed incentives for people to seek more affordable options or for a truly competitive marketplace.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented positive results from two pivotal Phase 3 clinical trials of the investigational product, PA32540, at The American Heart Association (AHA) Scientific Sessions 2012, as Poster #12057: Treatment Continuation and Cardiovascular Safety of Antiplatelet Therapy with PA32540, A Tablet with Enteric-Coated Aspirin and Immediate-Release Omeprazole: Results of Two 6-Month, Phase 3 Studies.
Workers who lost their job through no fault of their own were twice as likely as continuously employed workers to report over the next 18 months that they developed a new illness, such as high blood pressure, diabetes or heart disease, according to a study released last week, the New York Times reports.
› Verified 7 days ago
Dr. Jessica Lynn Hamill Schindler, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1234 Napier Ave, Lakeland Regional Medical Center, Saint Joseph, MI 49085 Phone: 269-982-4941 | |
Lauren Virginia Chatfield Miller, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1234 Napier Ave, Saint Joseph, MI 49085 Phone: 269-982-4941 | |
Zachary Taylor, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1234 Napier Ave, Saint Joseph, MI 49085 Phone: 269-927-5191 | |
Dr. Michael W Clark, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1234 Napier Ave, Saint Joseph, MI 49085 Phone: 269-983-8300 | |
Kevin Hoffman, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1234 Napier Ave, Saint Joseph, MI 49085 Phone: 269-982-4941 | |
Thomas Christopher Barker, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1234 Napier Ave, Saint Joseph, MI 49085 Phone: 208-863-9116 | |
Edward R Lutkus, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1234 Napier Ave, Saint Joseph, MI 49085 Phone: 269-983-8300 |